---
title: "復星醫藥：控股子公司藥品獲晚期實體瘤臨牀試驗批准"
description: "復星醫藥控股子公司復宏漢霖近日獲得國家藥監局批准，開展注射用 HLX43 聯合 HLX07 治療晚期/轉移性實體瘤的臨牀試驗，計劃進行 Ib/II 期試驗。HLX43 為靶向 PD-L1 的抗體偶聯藥物，HLX07 為針對 EGFR 的創新生物藥。研發投入約 15 萬元，全球尚無同類藥物獲批上市，投資者需注意研發風險。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/259482859.md"
published_at: "2025-09-30T08:51:30.000Z"
---

# 復星醫藥：控股子公司藥品獲晚期實體瘤臨牀試驗批准

> 復星醫藥控股子公司復宏漢霖近日獲得國家藥監局批准，開展注射用 HLX43 聯合 HLX07 治療晚期/轉移性實體瘤的臨牀試驗，計劃進行 Ib/II 期試驗。HLX43 為靶向 PD-L1 的抗體偶聯藥物，HLX07 為針對 EGFR 的創新生物藥。研發投入約 15 萬元，全球尚無同類藥物獲批上市，投資者需注意研發風險。

近日，上海復星醫藥控股子公司復宏漢霖收到國家藥監局同意，注射用 HLX43 聯合 HLX07 治療晚期/轉移性實體瘤可開展臨牀試驗，擬於境內開展 Ib/II 期試驗。HLX43 為靶向 PD - L1 的抗體偶聯藥物，HLX07 是針對 EGFR 靶點的創新生物藥。截至 2025 年 9 月 30 日，HLX43 多項臨牀研究在全球多地有序開展，HLX07 相關多項 II 期臨牀研究正於境內開展。截至 8 月，針對該治療方案累計研發投入約 15 萬元，全球尚無同類聯合用藥獲批上市。因藥品尚處臨牀試驗階段，研發存在風險，提醒投資者注意投資風險。

### Related Stocks

- [02696.HK - 復宏漢霖](https://longbridge.com/zh-HK/quote/02696.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| DC insider warns there's only one solution to America's economic crisis \| Opinion | A former U.S. Secretary of Labor reflects on the economic conditions 30 years ago, noting the creation of 200,000 jobs p | [Link](https://longbridge.com/zh-HK/news/276319692.md) |
| Major work-from-home shake-up proposed for millions of Australians: What it means for you | Should workers who can't WFH get higher pay or extra leave to level the playing field with remote staff? | [Link](https://longbridge.com/zh-HK/news/276401093.md) |
| U2 releases song 'American Obituary' honoring Renee Good | U2 has released a song titled "American Obituary" as a tribute to Renee Good, a mother killed by an ICE officer in Minne | [Link](https://longbridge.com/zh-HK/news/276275369.md) |
| B2B collections best practices: Strategies for record US liquidity crunch | With U.S. trade receivables hitting record highs, commercial organizations face a critical 30-day window to secure liqui | [Link](https://longbridge.com/zh-HK/news/276285837.md) |
| Big Blue Bubble Collaborates with T-Pain to Launch New 'Clubbox' Feature in My Singing Monsters | Big Blue Bubble has partnered with T-Pain to introduce a new feature called 'Clubbox' in the game My Singing Monsters. T | [Link](https://longbridge.com/zh-HK/news/276456899.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。